Although further studies are required to clarify the role of LYPD1 in the pathogenesis of SSc skin sclerosis, our study suggests that serum LYPD1 levels may be useful as a serological marker to evaluate the degree of SSc skin sclerosis and monitor therapeutic effects. Here, LYPD1 is linked to systemic sclerosis.